[1]张阳阳,孙 琮,杨兴嫕,等.炙甘草汤加减联合依那普利治疗慢性阻塞性肺疾病合并心力衰竭疗效研究[J].陕西中医,2021,(9):1219-1222.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.017]
　ZHANG Yangyang,SUN Cong,YANG Xingyi,et al.Efficacy study on modified Zhigancao decoction combined with enalapril in treatment of chronic obstructive pulmonary disease with heart failure[J].,2021,(9):1219-1222.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.017]
点击复制

炙甘草汤加减联合依那普利治疗慢性阻塞性肺疾病合并心力衰竭疗效研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年9期
页码:
1219-1222
栏目:
临床研究
出版日期:
2021-09-05

文章信息/Info

Title:
Efficacy study on modified Zhigancao decoction combined with enalapril in treatment of chronic obstructive pulmonary disease with heart failure
作者:
张阳阳; 孙 琮; 杨兴嫕; 王 芳; 胡小玉; 刘伟男; 王士汉
(六安市中医院肺病科,安徽 六安 237006)
Author(s):
ZHANG Yangyang; SUN Cong; YANG Xingyi; WANG Fang; HU Xiaoyu; LIU Weinan; WANG Shihan
(Department of Pulmonology,Lu'an Hospital of Traditional Chinese Medicine,Lu'an 237006,China)
关键词:
慢性阻塞性肺疾病;  心力衰竭;  炙甘草汤;  依那普利;  中医证候;  心肌损伤;  肺功能
Keywords:
Chronic obstructive pulmonary disease;  Heart failure;  Zhigancao decoction;  Enalapri;  Traditional Chinese medicine symptoms;  Myocardial injury;  Lung function
分类号:
R 714.253
DOI:
DOI:10.3969/j.issn.1000-7369.2020.09.017
文献标志码:
A
摘要:
目的:探讨炙甘草汤加减联合依那普利治疗慢性阻塞性肺疾病(COPD)合并心力衰竭(HF)疗效。方法:选取73例COPD合并HF患者为观察对象,随机分为两组。两组均给予常规治疗,在此基础上对照组口服依那普利,中药组在对照组基础上联合炙甘草汤加减进行治疗。比较两组患者治疗前后的临床疗效、中医证候积分、心肺功能及血清生化指标水平。结果:治疗后,中药组患者总有效率高于对照组,差异有统计学意义(P<0.05)。两组患者治疗后各中医证候积分、总分和血清生化指标较治疗前降低(均P<0.05)。患者心肺功能指标较治疗前改善,且治疗后上述指标组间比较,差异有统计学意义(均P<0.05)。两组患者在治疗过程中均未发生明显不良反应。结论:炙甘草汤加减联合依那普利治疗COPD合并HF患者,临床疗效较好,可改善患者中医证候、心肌损伤和肺功能,安全性较好。
Abstract:
Objective:To explore efficacy of modified Zhigancao decoction combined with enalapril in treatment of chronic obstructive pulmonary disease(COPD)with heart failure(HF).Methods:73 patients with COPD complicated with HF were selected as observation subjects,and randomly divided into two groups.Patients in two groups were given conventional treatment,the control group was given oral administration of enalapril on the basis,the traditional Chinese medicine group was combined with modified Zhigancao decoction on basis of the control group.The clinical efficacy,TCM syndromes scores,cardio-pulmonary function and levels of serum biochemical indicators were compared between the two groups before and after treatment.Results:After treatment,the total effective rate of the traditional Chinese medicine group was significant hingher than that in the control group(P<0.05).The scores of various syndromes and total score and levels of serum biochemical indicators of the two groups were significantly decreased compared with those before treatment(all P<0.05).The cardio-pulmonary function indicators of patients were significantly increased compared with those before treatment.There were significant differences in the above-mentioned indicators between the groups after treatment(all P<0.05).There were no adverse reactions in the two groups during treatment.Conclusion:Modified Zhigancao decoction combined with enalapril has significant clinical efficacy in the treatment of patients with COPD and HF.It can improve traditional Chinese medicine symptoms,myocardial injury and lung function.Its has better safely.

参考文献/References:

[1] 王 敏,陈 阁.清热化痰祛瘀方联合西药治疗慢性阻塞性肺疾病急性加重期患者的临床研究[J].陕西中医,2019,40(5):610-612.
[2] 孙丽敏,董绍臣,刘宏丽,等.慢性阻塞性肺疾病并心力衰竭患者血清胆碱酯酶活性变化及其临床意义[J].中国实验诊断学,2018,22(7):1140-1142.
[3] 王海丽,周剑平,孟 俊,等.慢性阻塞性肺病患者红细胞分布宽度与右心力衰竭竭的相关性研究[J].上海交通大学学报,2018,38(6):115-117.
[4] 谭 涛,吴 曦.依那普利联合瑞舒伐他汀对慢性心力衰竭患者血管内皮功能、氧自由基代谢以及血清炎性因子的影响[J].陕西医学杂志,2018,47(9):1192-1195.
[5] 张 娟,左昔清,章建良,等.慢性阻塞性肺疾病合并呼吸衰竭患者Th1/Th2变化趋势及中医辨证治疗对其影响的研究[J].中华中医药学刊,2016,34(2):451-455.
[6] 杨铁城,徐 玢,单 凯,等.急性心力衰竭急诊早期死亡风险预测临床研究[J].中国急救复苏与灾害医学杂志,2017,12(4):301-304.
[7] 张翕宇.炙甘草汤新解[J].中医学报,2017,32(1):64-66.
[8] 白 晶.从社会医学角度解读《慢性阻塞性肺疾病诊治指南》[J].医学与社会,2010,23(7):30-31,34.
[9] Ponikowski P,Voors AA,Anker SD,et al.ESC guidelines for the diagnosis and treatment of acute and chronic heart failure:The task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology developed with the special contribution of the heart failure association of the ESC[J].European Heart Journal,2016,37(27):2129-2200.
[10] 张会永,张 杰,马晓燕,等.中医内科学症状术语规范化研究[J].辽宁中医杂志,2011,38(6):1032-1033.
[11] 国家中医药管理局.中药新药临床研究指导原则[M].北京:中国医药科研究出版社,2002:107-110.
[12] 翟润晴,许西琳,刘 冬,等.慢性阻塞性肺疾病合并症的分布情况及相关危险因素分析[J].吉林医学,2017,38(8):1451-1454.
[13] 杨红亮,孟利敏.25-(OH)D3、NT-proBNP、PCT对老年慢性阻塞性肺疾病合并心力衰竭患者近期预后的影响[J].中国循证心血管医学杂志,2017,9(4):443-445,448.
[14] 杜高波,张 丹,余 强,等.曲美他嗪联用血管紧张素转化酶抑制剂(ACEI)治疗慢性心力衰竭的Meta分析[J].药物评价研究,2019,42(12):2444-2450.
[15] 陈 麒,田 君,蒋 骏,等.改良中医呼吸导引康复技术治疗慢性阻塞性肺疾病稳定期患者的临床观察[J].上海中医药大学学报,2017,31(3):33-39.
[16] 胡 涛,林 琳,王 谦.五脏相关理论在慢性阻塞性肺疾病防治中的应用及拓展[J].中华中医药杂志,2016,31(2):367-369.
[17] 郑 鑫,李泊萱,王贤良.从阴阳辨治慢性心力衰竭验案举隅[J].中西医结合心脑血管病杂志,2020,18(22):3896-3897.
[18] 周益平,熊 熙,王春霞,等.心型脂肪酸结合蛋白在儿童严重脓毒症及脓毒性休克中的意义[J].中华急诊医学杂志,2018,27(6):605-610.
[19] 朱 芮,杨张朔,习一清,等.脑钠肽及氮端脑钠肽在窒息新生儿心肌损伤中的应用[J].中华实验外科杂志,2017,34(10):1775-1777.
[20] 韦梦莹.“甘草附子汤”中甘草及黄酮类组分的药效学研究[D].长春:吉林大学,2016.
[21] 许 瑞,王 丹,王 研,等.梓醇对2型糖尿病大鼠心肌细胞氧化应激及心功能的影响[J].国际中医中药杂志,2019,41(5):476-480.

相似文献/References:

[1]岳珍珍,何胜男,焦义明.振源胶囊联合心理干预治疗慢性心衰疗效及对患者情绪影响*[J].陕西中医,2019,(3):300.
　YUE Zhenzhen,HE Shengnan,JIAO Yiming..Effect of Zhenyuan capsule combined with psychological intervention on efficacy, safety and negative emotions of chronic heart failure[J].,2019,(9):300.
[2]杨栓柱,王 文 △,李 猛,等.千金苇茎汤合瓜蒌薤白杏仁汤治疗 慢性阻塞性肺疾病急性加重期临床研究*[J].陕西中医,2019,(5):600.
[3]王 敏,陈 阁.清热化痰祛瘀方联合西药治疗慢性阻塞性肺疾病急性 加重期患者的临床研究[J].陕西中医,2019,(5):610.
　WANG Min,CHEN Ge..Clinical study of Qingre Huatan Quyu prescription combined with western medicine in the treatment of acute exacerbation of chronic obstructive pulmonary disease[J].,2019,(9):610.
[4]李天浩,韩晨旭,王惠琴,等.基于EGFR-MUC5AC信号通路探讨参鱼化痰口服液干预慢性阻塞性肺疾病大鼠气道黏液高分泌的机制*[J].陕西中医,2019,(8):995.
　LI Tianhao,HAN Chenxu,WANG Huiqin,et al.Based on EGFR-MUC5AC signaling pathway to explore the mechanism of Shenyu Huatan oral liquid in intervention of airway mucus high secretion in COPD rats[J].,2019,(9):995.
[5]王珊珊,谭光波△.补肺汤对慢性阻塞性肺疾病肺气肿大鼠血清IFNγ、IL4表达水平影响研究*[J].陕西中医,2019,(11):1491.
　WANG Shanshan,TAN Guangbo..Effect of Bufei decoction on the expression of IFNγ and IL4 in serum of rats with chronic obstructive pulmonary disease and emphysema[J].,2019,(9):1491.
[6]任英杰,王 起,陈秋生.黄芪汤加减治疗急性加重期慢性阻塞性肺疾病疗效研究[J].陕西中医,2020,(1):57.
　REN Yingjie,WANG Qi,CHEN Qiusheng..Observation on the curative effect of Huangqi decoction in the treatment ofacute exacerbation of chronic obstructive pulmonary disease[J].,2020,(9):57.
[7]聂清华,范伏元△.射干麻黄汤联合沙丁胺醇对慢性阻塞性肺疾病患者肺功能、生活质量的影响[J].陕西中医,2020,(2):180.
　NIE Qinghua,FAN Fuyuan..Effects of Shegan Mahuang decoction and albuterol on pulmonary function and quality of life in patients with COPD[J].,2020,(9):180.
[8]刘新平,王展儒.理肺化痰通脉方治疗慢性阻塞性肺疾病急性加重期临床研究[J].陕西中医,2020,(4):484.
[9]宋金玉,杜 鑫,施继红,等.芪苈强心胶囊联合米力农对心肌梗死合并心力衰竭患者动脉血流和心功能的影响*[J].陕西中医,2020,(4):493.
[10]杜沂岚,唐 敏,陈朝晖△,等.经肺腧穴中药离子导入联合振动排痰治疗慢性阻塞性肺疾病急性加重期临床疗效*[J].陕西中医,2020,(4):534.
　DU Yilan,TANG Min,CHEN Zhaohui,et al.Clinical efficacy of Chinese medicine iontophoresis via Feishu point combined with vibration sputum discarding in the treatment of AECOPD[J].,2020,(9):534.

备注/Memo

备注/Memo:
基金项目:北京白求恩基金会医学科学研究基金资助项目(SCZ290EN)
更新日期/Last Update: 2021-09-10